Healthcare
Verisante Technology Inc.(VRSEF)
Live Price
Offline$0.0021
+0.00% today
1Y Change
-4.55%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- โ
- Revenue Growth
- 0.0%
- EPS Growth
- +125.9%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Verisante Technology Inc. (VRSEF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 4.5% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +125.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +125.9%, free cash flow 0.0% with operating margin 0.0% and ROIC 1169.8%. Valuation is more restrained than many high-expectation growth names at P/E 2.1. Stock Foundry combines VRSEF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
P/E
Below sector median
2.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 20, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +125.9%, while operating margin sits near 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.6% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 20, 2026 | โ | +0.0% | +0.0% | +109.1% |
2025 Oct 24, 2025 | โ | +0.0% | +4.8% | +0.0% |
2025 Aug 18, 2025 | โ | +0.0% | +0.0% | +150.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VRSEF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
VRSEF Max Drawdown
-98.46%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for VRSEF and SPY.
Company Overview
Verisante Technology Inc.
Other OTC
Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of innovative cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. The company was incorporated in 2006 and is based in Vancouver, Canada.
- Leadership
- Thomas A. Braun
- IPO Date
- May 6, 2011
- Employees
- 18
- Street Address
- 422 Richards Street
- Mailing
- Vancouver, BC, V6B
- Region
- Vancouver, BC, CA
- Reporting Currency
- USD
- Investor Line
- +1 604 605 0507
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 2.1
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- +125.9%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- -29.5%
- ROIC
- 1169.8%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.33
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.